BRCA2 and serous adenocarcinoma: Although we had no information about their age at the time of diagnosis, the mean age at molecular diagnosis was 48.63 years (range: 30-74 years).On the other hand, 20.7%(n=79/382) of OC patients had germline BRCA1/2 P/LP variants with 64.8% (n=51/79) of them in BRCA1 and 35.44% (n=28/79) in BRCA2. Regarding the histological subtypes of BRCA1/2 OC patients, it was observed that 91.1% (n=72/79) were characterized by high-grade serous carcinoma, followed by endometrioid carcinoma (n=5/79, 6.3%) and clear cell carcinoma (n=2/79, 2.53%).